Mlkl Conditional Knockout mouse models

Mlkl encodes mixed lineage kinase domain like protein, the mouse ortholog of human MLKL and the terminal executioner of necroptosis, built from an N-terminal four helix bundle killer domain, a brace region, and a catalytically dead pseudokinase domain that serves as a molecular latch. RIPK3 phosphorylates the activation loop at Ser345 in mouse, releasing the bundle to oligomerize, bind phosphatidylinositol phosphates, and permeabilize the plasma membrane, and the equivalent human activation sites and conformational requirements differ enough that murine and human proteins are not interchangeable for inhibitor testing. Nulls are viable and fertile and rescue the embryonic lethality of Casp8 or Fadd deletion, whereas phosphomimetic constitutively active knockins are lethal, so inducible expression is mandatory for gain-of-function work. Because species divergence is the central obstacle, humanized MLKL knockins are the informative allele for translational pharmacology, while conditional nulls with tissue restricted Cre lines partition necroptosis in ischemia, colitis, and kidney injury.

Mlkl conditional knockout mice carry a floxed allele so you delete function only where Cre is active. The germline allele stays intact until you cross to a tissue specific Cre. Labs reach for this design when a global knockout is lethal, when they need adult onset loss, or when regional redundancy hides a whole body phenotype.